Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non–Small Cell Lung Cancer

Jie Lei(Air Force Medical University), Tao Jiang(Air Force Medical University), Guangyan Lei, Xiaolong Yan(Air Force Medical University), Ende Yang(Air Force Medical University), Zhigang Liu, Xiaojing Wang(First Affiliated Hospital of Bengbu Medical College), Cheng Wang(Lanzhou University Second Hospital), Tao Wang(Air Force Medical University), Yongan Zhou(Air Force Medical University), Zhongping Gu(Air Force Medical University), Honggang Liu(Capital University), Jinbo Zhao(Air Force Medical University), Qiang Lü(Air Force Medical University), Li Gong(Xi'an Medical University), Lijun Huang(Air Force Medical University), Daixing Zhong(Air Force Medical University), Zhengwei Zhao(Air Force Medical University), Yunfeng Ni(Air Force Medical University), Xiaoping Wang(Jiangsu Hengrui Medicine (China)), Feng Tian(Air Force Medical University), Jian Wang(BGI Group (China)), Jianyong Sun(Sun Yat-sen University)
JAMA Oncology
August 3, 2023
Cited by 96


Related Papers